Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. Issue 1 (31st December 2023)
- Record Type:
- Journal Article
- Title:
- Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. Issue 1 (31st December 2023)
- Main Title:
- Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
- Authors:
- Ning, Yating
Xiao, Meng
Perlin, David S.
Zhao, Yanan
Lu, Minya
Li, Yi
Luo, Zhengyu
Dai, Rongchen
Li, Shengjie
Xu, Jiajun
Liu, Lingli
He, Hong
Liu, Yun
Li, Fushun
Guo, Yuguang
Chen, Zhongju
Xu, Yingchun
Sun, Tianshu
Zhang, Li - Abstract:
- ABSTRACT: Candida parapsilosis is becoming a predominant non- albicans cause of invasive candidiasis (IC). Echinocandins are the preferred choice for IC treatment and prophylaxis. Resistance to echinocandins in C. parapsilosis has emerged in several countries, but little is known about the susceptibility profile in China or about mechanisms of resistance. Here, we investigated the echinocandin susceptibilities of 2523 C. parapsilosis isolates collected from China and further explored the resistance mechanism among echinocandin-resistant isolates. Anidulafungin exhibited the highest MICs (MIC50/90, 1 and 2 µg/mL; GM, 0.948 µg/mL), while caspofungin showed better activity (0.5 and 1 µg/mL; 0.498 µg/mL). Significantly higher echinocandin MICs were observed among blood-derived isolates compared to others, especially for caspofungin (GM, 1.348 µg/mL vs 0.478 µg/mL). Isolates from ICU and surgical wards also showed higher MICs. Twenty isolates showed intermediate phenotypes for at least one echinocandin. One was resistant to all three echinocandins, fluconazole and voriconazole, which caused breakthrough IC during long-term exposure to micafungin. WGS revealed this isolate carried a mutation S656P in hotspot1 region of Fks1. Bioinformatics analyses suggested that this mutation might lead to an altered protein conformation. CRISPR Cas9-mediated introduction of this mutation into a susceptible reference C. parapsilosis strain increased MICs of all echinocandins 64-fold, with similarABSTRACT: Candida parapsilosis is becoming a predominant non- albicans cause of invasive candidiasis (IC). Echinocandins are the preferred choice for IC treatment and prophylaxis. Resistance to echinocandins in C. parapsilosis has emerged in several countries, but little is known about the susceptibility profile in China or about mechanisms of resistance. Here, we investigated the echinocandin susceptibilities of 2523 C. parapsilosis isolates collected from China and further explored the resistance mechanism among echinocandin-resistant isolates. Anidulafungin exhibited the highest MICs (MIC50/90, 1 and 2 µg/mL; GM, 0.948 µg/mL), while caspofungin showed better activity (0.5 and 1 µg/mL; 0.498 µg/mL). Significantly higher echinocandin MICs were observed among blood-derived isolates compared to others, especially for caspofungin (GM, 1.348 µg/mL vs 0.478 µg/mL). Isolates from ICU and surgical wards also showed higher MICs. Twenty isolates showed intermediate phenotypes for at least one echinocandin. One was resistant to all three echinocandins, fluconazole and voriconazole, which caused breakthrough IC during long-term exposure to micafungin. WGS revealed this isolate carried a mutation S656P in hotspot1 region of Fks1. Bioinformatics analyses suggested that this mutation might lead to an altered protein conformation. CRISPR Cas9-mediated introduction of this mutation into a susceptible reference C. parapsilosis strain increased MICs of all echinocandins 64-fold, with similar results found in the subspecies, C. orthopsilosis and C. metapsilosis . This is the first report of a multi-azole resistant and pan-echinocandin resistant C. parapsilosis isolate, and the identification of a FKS1 S656P conferring pan-echinocandin resistance. Our study underscores the necessity of rigorous management of antifungal use and of monitoring for antifungal susceptibility. … (more)
- Is Part Of:
- Emerging microbes & infections. Volume 12:Issue 1(2023)
- Journal:
- Emerging microbes & infections
- Issue:
- Volume 12:Issue 1(2023)
- Issue Display:
- Volume 12, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 12
- Issue:
- 1
- Issue Sort Value:
- 2023-0012-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-12-31
- Subjects:
- Candida parapsilosis -- echinocandin resistance -- breakthrough candidemia -- FKS1 -- S656P
Medical microbiology -- Periodicals
Communicable diseases -- Periodicals
Infection -- Periodicals
616.9041 - Journal URLs:
- http://www.nature.com/ ↗
https://www.nature.com/emi/ ↗ - DOI:
- 10.1080/22221751.2022.2153086 ↗
- Languages:
- English
- ISSNs:
- 2222-1751
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24809.xml